Back
Elite Pharmaceuticals Vs. Zevra Therapeutics Industry Stock Comparison
Sell
50
ELTP
Elite Pharmaceuticals
Last Price:
0.50
Seasonality Move:
11.78%
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
8.86
Seasonality Move:
3.19%
Sell
50
Elite Pharmaceuticals (ELTP)
is a Sell
Is Elite Pharmaceuticals a Buy, Sell or Hold?
- The current Elite Pharmaceuticals [ELTP] share price is $0.52. The Score for ELTP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ELTP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $8.80. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ELTP Stock Price Chart
What is Elite Pharmaceuticals's stock price today?
-
The Elite Pharmaceuticals share price today is $0.52
The current trend is moderately bullish and ELTP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $8.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
ELTP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 54.03 | Buy |
Chaikin Money Flow: | 497804 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.4 - 0.56) | Buy |
Bollinger Bands (100): | (0.17 - 0.43) | Buy |
ZVRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 62.5 | Buy |
Chaikin Money Flow: | 165819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.79 - 8.59) | Buy |
Bollinger Bands (100): | (5.7 - 8.18) | Buy |
ELTP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.5 | Buy |
20-day SMA: | 0.5 | Buy |
50-day SMA: | 0.42 | Buy |
200-day SMA: | 0.23 | Buy |
8-day EMA: | 0.51 | Buy |
20-day EMA: | 0.49 | Buy |
50-day EMA: | 0.42 | Buy |
200-day EMA: | 0.26 | Buy |
ZVRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.41 | Buy |
20-day SMA: | 8.29 | Buy |
50-day SMA: | 7.82 | Buy |
200-day SMA: | 6.18 | Buy |
8-day EMA: | 8.47 | Buy |
20-day EMA: | 8.25 | Buy |
50-day EMA: | 7.81 | Buy |
200-day EMA: | 6.49 | Buy |
Elite Pharmaceuticals Earnings Growth & ELTP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $1.26 per share.
Elite Pharmaceuticals Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Zevra Therapeutics Technical Analysis
Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |